Brandinium

Trademark search for:

ZORBLISA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2023-09-25 — Application filed
  • 2023-09-25 — Application filed
  • 2023-12-12 — Application filed
  • 2024-04-09 — Suspension letter written
  • 2024-04-09 — Notification of letter of suspension e-mailed
  • 2024-04-09 — Letter of suspension e-mailed
  • 2024-04-09 — Assigned to examiner
  • 2024-04-30 — Teas response to suspension inquiry received
  • 2024-09-16 — Approved for pub - principal register
  • 2024-09-16 — Correspondence received in law office
  • 2024-09-16 — Teas/email correspondence entered
  • 2024-09-16 — Assigned to lie
  • 2024-10-02 — Notification of notice of publication e-mailed
  • 2024-10-22 — Published for opposition
  • 2024-10-22 — Official gazette publication confirmation e-mailed
  • 2024-12-03 — Noa e-mailed - sou required from applicant
  • 2025-07-07 — Application abandoned
  • 2025-07-07 — Application abandoned
  • 2025-07-07 — Final status recorded

Owner Information

Paradigm Therapeutics, Inc.
Mt. Pleasant , SC
Paradigm Therapeutics, Inc.
Mt. Pleasant , SC

Correspondent

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
1101 K Street, NW
10th Floor
Washington, DC 20005

Filing Details

Filing Date:
2023-09-25
Status Date:
2025-07-07
Category:
Pharmaceuticals
Filing Year:
2014

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.